Directory
>
Anahita Bhathena
Anahita Bhathena
Executive Director, Calico Translational Biology | AbbVie
Evanston, Illinois, United States
Anahita Bhathena
AI Summary
Anahita Bhathena is an accomplished executive in the pharmaceutical industry with a strong focus on translational medicine and oncology. Currently serving as the Executive Director of Calico Translational Biology at AbbVie, she brings over a decade of leadership experience in drug development and clinical research. Anahita has a robust background in biomarker development and clinical trials, making significant contributions to cancer research initiatives. With a PhD in Pharmacology from the University of Toronto, her academic foundation complements her extensive professional experience. Anahita has held various roles at AbbVie and Abbott Laboratories, demonstrating a commitment to advancing precision medicine. She is passionate about leveraging innovative technologies to improve patient outcomes and drive the future of healthcare. Outside of her professional endeavors, she is likely to be involved in mentoring the next generation of scientists and leaders in the life sciences sector.
Anahita Bhathena
Work Experience
Executive Director, Calico Translational Biology at
AbbVie
September 2022 - Present
Head, Precision Medicine Oncology, Executive Director at
AbbVie
August 2018 - Present
Director at
AbbVie
May 2016 - August 2018
Associate Director at
Abbvie Biopharmaceuticals
January 2013 - May 2016
Associate Director I - Translational Biology and Tumor Genomics, Cancer Research at
Abbott
January 2010 - January 2013
Group Leader, Pharmacogenetics at
Abbott
January 2008 - January 2010
Anahita Bhathena
Education
January 1991 - January 2002
Frequently Asked Questions about Anahita Bhathena
What is Anahita Bhathena email address?
Anahita Bhathena's primary email address is ***************@hotmail.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Anahita Bhathena work for?
Anahita Bhathena is a Executive Director, Calico Translational Biology at AbbVie, a company specializing in Pharmaceutical & Medicine Manufacturing.
Where Anahita Bhathena graduated from?
Anahita Bhathena holds a degree in Pharmacology from University of Toronto.
How can I directly contact Anahita Bhathena?
To contact Anahita Bhathena directly, you can use the email address ***************@hotmail.com. Complete contact information is available upon registration with Muraena.
Who is Anahita Bhathena?
Anahita Bhathena is an accomplished executive in the pharmaceutical industry with a strong focus on translational medicine and oncology. Currently serving as the Executive Director of Calico Translational Biology at AbbVie, she brings over a decade of leadership experience in drug development and clinical research. Anahita has a robust background in biomarker development and clinical trials, making significant contributions to cancer research initiatives. With a PhD in Pharmacology from the University of Toronto, her academic foundation complements her extensive professional experience. Anahita has held various roles at AbbVie and Abbott Laboratories, demonstrating a commitment to advancing precision medicine. She is passionate about leveraging innovative technologies to improve patient outcomes and drive the future of healthcare. Outside of her professional endeavors, she is likely to be involved in mentoring the next generation of scientists and leaders in the life sciences sector.
Anahita`s contact details
***************@hotmail.com
****************@abbvie.com
Colleagues
Vice President, Search and Evaluation & Global Alliances
Founder
Senior Vice President, Chief Ethics and Compliance Officer and Allergan Aesthetics Legal
Vice President, International Marketing and Commercial Operations
Vice President, Regulatory Affairs (Regulatory Intercontinental, Regulatory Policy & Intelligence)
Vice President Europe Region North
VP and Head, US Commercial BTS, Patient Services, Market Access and Commercial Data Mgmt.
GMA Chief of Staff, Director of Global Initiatives & Communication
Vice President, Health Economics and Outcomes Research (Immunology, Oncology & Neuroscience)
Vice President WesternEurope & Canada